Streetbeat News

Products Services

VANI

Vivani Medical announced that the clinical development of its exenatide implant for overweight and obese patients is on track to begin in Q4 2024 as part of its NPM-115 program.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:30 am

VANI

Vivani Medical announced that its GLP-1 (exenatide) implant achieved an 82% reduction in liver fat in an obese mouse model with a single administration, suggesting potential for twice-yearly dosing.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:30 am

VANI

Vivani Medical has announced preclinical results for its miniature, ultra long-acting GLP-1 implant, which targets liver fat reduction. This development could have implications for the company's future product offerings and market position.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:30 am

NVDA

SPY

USO

U.S. stocks experienced a significant decline, with the S&P 500, Nasdaq, and Dow seeing their steepest losses since early August. Nvidia's sharp drop of nearly 10% contributed to the broader market decline. Weaker manufacturing data and uncertainty over Federal Reserve interest rate cuts dampened investor sentiment. Most S&P 500 sectors fell, particularly energy, tech, and communication services, while real estate and consumer staples gained. Asian and European markets also saw declines, and crude oil prices fell below $70.

Portfolio Pulse from Akanksha Bakshi

September 04, 2024 | 11:26 am

HRL

Hormel Foods Corporation (NYSE:HRL) revised its FY24 outlook due to production disruptions, causing its stock to drop. Despite beating EPS estimates, sales missed expectations, and the company faces challenges in its Retail and International segments. Hormel anticipates continued growth in its Foodservice segment and improvements in its supply chain.

Portfolio Pulse from Nabaparna Bhattacharya

September 04, 2024 | 11:25 am

ONTO

Onto Innovation has opened a new Packaging Applications Center of Excellence in the US, focusing on panel-level packaging innovations for 2.5D and 3D chiplet architectures and AI packages.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:19 am

CYN

Cyngn has been granted a new U.S. patent (No. 12,032,099) for a method to maintain the accuracy of data collected by autonomous vehicle sensors. This development could enhance the performance and reliability of Cyngn's autonomous vehicle technology.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:17 am

TSLA

Tesla enthusiasts drove Cybertrucks from Florida to the Arctic Ocean, showcasing the vehicle's capabilities. Despite the Cybertruck's range limitations, Tesla plans to offer a range extender and ramp up production. The journey highlights Tesla's commitment to innovation and customer engagement.

Portfolio Pulse from Anan Ashraf

September 04, 2024 | 11:17 am

QCOM

Qualcomm has announced the expansion of its performance leadership with the introduction of the new Snapdragon X Plus 8-core processor, aimed at enhancing the capabilities of Copilot+ PC users. This development is expected to strengthen Qualcomm's position in the PC market.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:16 am

IVVD

Invivyd has commenced dosing in a Phase 1 clinical trial for VYD2311, a new monoclonal antibody candidate for COVID-19. This marks a significant step in the development of potential treatments for the virus.

Portfolio Pulse from Benzinga Newsdesk

September 04, 2024 | 11:16 am